Duloxetine - Pain (Neuropathic)
You are here : Home > Formulary Search > Duloxetine - Pain (Neuropathic)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (Local)
PAD Profile
ChemicalSubstance :
Duloxetine
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
neuropathic pain, diabetic neuropathy, postherpetic neuralgia, PHN
Brand Names Include :
Cymbalta
Important Information :
Licensed only for diabetic peripheral neuropathic pain but also recommended as per NICE CG173 (off- label indication) as a treatment option in neuropathic pain.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Duloxetine is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Pain (Neuropathic).
Committee Recommendations (2)
Duloxetine 60mg once daily or amitriptyline are recommended as treatment options at step 1 of the local neuropathic pain guidelines..
Duloxetine is licensed only for diabetic peripheral neuropathic pain but is also recommended by NICE as a treatment option in neuropathic pain.
See guidelines below.
GENERIC Duloxetine has been considered by the PCN and has been assigned a GREEN traffic light status
NOTE - the branded product, Cymbalta, was considered BLACK at the PCN in May 2017.
NOTE - the branded product, Cymbalta, was considered BLACK at the PCN in May 2017.